S

Surgical Science Sweden AB
STO:SUS

Watchlist Manager
Surgical Science Sweden AB
STO:SUS
Watchlist
Price: 146.1 SEK Market Closed
Market Cap: 7.5B SEK
Have any thoughts about
Surgical Science Sweden AB?
Write Note
Section:
 

Relative Value

The Relative Value of one SUS stock under the Base Case scenario is 205.41 SEK. Compared to the current market price of 146.1 SEK, Surgical Science Sweden AB is Undervalued by 29%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SUS Relative Value
Base Case
205.41 SEK
Undervaluation 29%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

8.7
P/S
P/S
Price to Sales
8.7
vs History
87
vs Industry
16
Median 3Y
10.4
Median 5Y
15.8
Industry
2.4
Forward
8.2
More Details
38.6
P/E
P/E
Price to Earnings
38.6
vs History
77
vs Industry
16
Median 3Y
44.2
Median 5Y
93.7
Industry
23.1
Forward
50.2
More Details
62
P/OCF
P/OCF
Price to OCF
62
vs History
47
vs Industry
11
Median 3Y
57.9
Median 5Y
57.9
Industry
14.6
More Details
99
P/FCFE
P/FCFE
Price to FCFE
99
vs History
23
vs Industry
13
Median 3Y
63.1
Median 5Y
62
Industry
20.3
More Details
1.7
P/B
P/B
Price to Book Value
1.7
vs History
87
vs Industry
51
Median 3Y
2
Median 5Y
2.7
Industry
2.2
More Details
7.9
EV/S
EV/S
Enterprise Value to Sales
7.9
vs History
87
vs Industry
16
Median 3Y
9.8
Median 5Y
15.5
Industry
2.4
Forward
7.4
More Details
11.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
11.5
vs History
87
vs Industry
19
Median 3Y
14.4
Median 5Y
22.4
Industry
5
More Details
47.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
47.5
vs History
66
vs Industry
7
Median 3Y
45.8
Median 5Y
83.2
Industry
12.8
Forward
29.3
More Details
47.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
47.5
vs History
69
vs Industry
9
Median 3Y
48.4
Median 5Y
101.7
Industry
17.4
Forward
35
More Details
56.5
EV/OCF
EV/OCF
Enterprise Value to OCF
56.5
vs History
47
vs Industry
13
Median 3Y
54.5
Median 5Y
54.5
Industry
14.4
More Details
93
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
93
vs History
42
vs Industry
12
Median 3Y
79.8
Median 5Y
79.8
Industry
18.1
More Details
1.6
EV/IC
EV/IC
Enterprise Value to IC
1.6
vs History
82
vs Industry
47
Median 3Y
1.8
Median 5Y
2.7
Industry
1.9
More Details

Multiples Across Competitors

SUS Competitors Multiples
Surgical Science Sweden AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Surgical Science Sweden AB
STO:SUS
7.5B SEK 8.7 38.6 47.5 47.5
US
Abbott Laboratories
NYSE:ABT
204.9B USD 5 35.5 20.7 30.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
195.2B USD 24.8 87 74.3 92.2
US
Stryker Corp
NYSE:SYK
146.7B USD 6.7 40.9 26.5 32.2
US
Boston Scientific Corp
NYSE:BSX
132.6B USD 8.3 74 33.9 48.5
IE
Medtronic PLC
NYSE:MDT
110.6B USD 3.4 28.2 14.7 21
US
Becton Dickinson and Co
NYSE:BDX
64.7B USD 3.2 37.5 15.6 27.9
DE
Siemens Healthineers AG
XETRA:SHL
55.6B EUR 2.5 29.8 17.1 24.9
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
319.2B CNY 8.6 25.1 22.1 22.1
US
Edwards Lifesciences Corp
NYSE:EW
41.6B USD 7.4 10 22.1 24.2
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
37.7B USD 1.9 22.5 14 17.3

See Also

Summary
SUS intrinsic value, competitors valuation, and company profile.
DCF Valuation
SUS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SUS stock valuation using valuation multiples.
Wall Street Estimates
SUS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SUS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 201,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.